1. AXICABTAGENE CILOLEUCEL (AXI‐CEL; KTE‐C19) IN PATIENTS WITH REFRACTORY AGGRESSIVE NON‐HODGKIN LYMPHOMAS (NHL): PRIMARY RESULTS OF THE PIVOTAL TRIAL ZUMA‐1. (June 2017) Authors: Neelapu, S.S.; Locke, F.L.; Bartlett, N.L.; Lekakis, L.J.; Miklos, D.; Jacobson, C.A.; Braunschweig, I.; Oluwole, O.; Siddiqi, T.; Lin, Y.; Timmerman, J.; Reagan, P.; Navale, L.; Jiang, Y.; Aycock, J.; Elias, M.; Wiezorek, J.; Go, W.Y. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY BY BASELINE TUMOR BURDEN IN ADULTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL. (12th June 2019) Authors: Maziarz, R.T.; Schuster, S.J.; Ericson, S.G.; Rusch, E.S.; Signorovitch, J.; Li, J.; Romanov, V.V.; Maloney, D.G.; Locke, F.L. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OUTCOMES OF PATIENTS ≥ 65 YEARS OF AGE IN ZUMA‐1, A PIVOTAL PHASE 1/2 STUDY OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) IN REFRACTORY LARGE B CELL LYMPHOMA. (12th June 2019) Authors: Neelapu, S.S.; Jacobson, C.A.; Oluwole, O.O.; Munoz, J.; Deol, A.; Miklos, D.B.; Bartlett, N.L.; Braunschweig, I.; Jiang, Y.; Kim, J.J.; Zheng, L.; Rossi, J.M.; Locke, F.L. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PRODUCT CHARACTERISTICS ASSOCIATED WITH IN VIVO EXPANSION OF ANTI‐CD19 CAR T CELLS IN PATIENTS TREATED WITH AXICABTAGENE CILOLEUCEL (AXI‐CEL). (June 2017) Authors: Neelapu, S.S.; Rossi, J.M.; Locke, F.L.; Xue, A.; Better, M.; Zhang, X.; Ghobadi, A.; Lekakis, L.J.; Miklos, D.; Jacobson, C.A.; Braunschweig, I.; Oluwole, O.; Siddiqi, T.; Lin, Y.; Timmerman, J.; Reagan, P.M.; Navale, L.; Go, W.Y.; Wiezorek, J.; Bot, A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAFETY AND EFFICACY OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) IN OLDER PATIENTS: RESULTS FROM THE US LYMPHOMA CAR‐T CONSORTIUM. (12th June 2019) Authors: Sano, D.; Lekakis, L.; Feng, L.; Nastoupil, L.J.; Jain, M.D.; Spiegel, J.Y.; Dahiya, S.; Lin, Y.; Ghobadi, A.; Lunning, M.; Hill, B.T.; Reagan, P.; Oluwole, O.; McGuirk, J.; Sehgal, A.; Deol, A.; Charalambos, A.; Goy, A.H.; Munoz, J.; Cashen, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗